Skip to main content
Clinical Trials/NCT02979158
NCT02979158
Completed
Not Applicable

Influence of Cardiopulmonary Bypass on Platelet Function in Patients With Preoperative Dual Antiplatelet Therapy:

Umeå University1 site in 1 country60 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiopulmonary Bypass
Sponsor
Umeå University
Enrollment
60
Locations
1
Primary Endpoint
Assessment of platelet function following cardiopulmonary bypass using platelet aggregometry
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Patients admitted for coronary artery bypass surgery taking antiplatelet medicine have an increased risk for bleeding.

Present study aims to compare the platelet function in two patient groups using different types of heart-lung machine methods.

It is assumed that one of the methods is superior verified by sensitive methods of testing platelet function.

Detailed Description

Taking antiplatelet medication before cardiac surgery increases the risk for bleeding. The surgical procedure and the use of a heart-lung machine may disturb the function of platelets, why measures to protect the existing function of platelets are of prime concern. The present study aims to compare how two types of heart-lung machine methods influence platelet function in two groups of patients. The platelet function will be tested before, during and after surgery by the use of two independent methods.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
January 24, 2018
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients accepted for coronary bypass surgery with dual preoperative antiplatelet therapy suspended less than 4 days prior to surgery

Exclusion Criteria

  • Abnormal coagulation verified from preoperative assessments, platelet count \<100 000, Warfarin medication and renal insufficiency (GFR \< 60 ml/min)

Outcomes

Primary Outcomes

Assessment of platelet function following cardiopulmonary bypass using platelet aggregometry

Time Frame: Test of platelet function will be analysed on arrival to the operating room, post cardiopulmonary bypass and on day 1 in the intensive care unit based on the area under the curve depited from the two employed aggremometers

Included aggregometry tests: Multiplate and Rotem Platelet

Secondary Outcomes

  • Postoperative bleeding(Postoperative bleeding 24 hrs)

Study Sites (1)

Loading locations...

Similar Trials